1. Home
  2. CBRE vs RMD Comparison

CBRE vs RMD Comparison

Compare CBRE & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBRE
  • RMD
  • Stock Information
  • Founded
  • CBRE 1906
  • RMD 1989
  • Country
  • CBRE United States
  • RMD United States
  • Employees
  • CBRE N/A
  • RMD N/A
  • Industry
  • CBRE Real Estate
  • RMD Medical/Dental Instruments
  • Sector
  • CBRE Finance
  • RMD Health Care
  • Exchange
  • CBRE Nasdaq
  • RMD Nasdaq
  • Market Cap
  • CBRE 40.0B
  • RMD 35.7B
  • IPO Year
  • CBRE 2004
  • RMD 1995
  • Fundamental
  • Price
  • CBRE $136.90
  • RMD $239.79
  • Analyst Decision
  • CBRE Strong Buy
  • RMD Buy
  • Analyst Count
  • CBRE 9
  • RMD 12
  • Target Price
  • CBRE $145.44
  • RMD $236.44
  • AVG Volume (30 Days)
  • CBRE 1.9M
  • RMD 814.8K
  • Earning Date
  • CBRE 02-13-2025
  • RMD 01-30-2025
  • Dividend Yield
  • CBRE N/A
  • RMD 0.88%
  • EPS Growth
  • CBRE 66.15
  • RMD 22.60
  • EPS
  • CBRE 3.10
  • RMD 7.54
  • Revenue
  • CBRE $34,313,000,000.00
  • RMD $4,807,485,000.00
  • Revenue This Year
  • CBRE $13.52
  • RMD $10.22
  • Revenue Next Year
  • CBRE $11.13
  • RMD $7.30
  • P/E Ratio
  • CBRE $44.11
  • RMD $31.80
  • Revenue Growth
  • CBRE 10.00
  • RMD 9.88
  • 52 Week Low
  • CBRE $82.75
  • RMD $170.48
  • 52 Week High
  • CBRE $142.00
  • RMD $260.49
  • Technical
  • Relative Strength Index (RSI)
  • CBRE 59.40
  • RMD 55.78
  • Support Level
  • CBRE $120.26
  • RMD $227.26
  • Resistance Level
  • CBRE $133.92
  • RMD $240.60
  • Average True Range (ATR)
  • CBRE 3.20
  • RMD 4.84
  • MACD
  • CBRE 0.72
  • RMD 0.97
  • Stochastic Oscillator
  • CBRE 97.94
  • RMD 94.19

About CBRE CBRE Group Inc

CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: